• 1. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 2. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 3. An atom-economical protocol for direct conversion of Baylis–Hillman alcohols to β-chloro aldehydes in water?
  Raktani Bikshapathi,Sai Prathima Parvathaneni,Vaidya Jayathirtha Rao Green Chem., 2017,19, 4446-4450
• 4. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 5. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453

Introduction to 2-Iodo-5-(trifluoromethyl)pyrimidine (CAS No. 112930-95-7)

2-Iodo-5-(trifluoromethyl)pyrimidine, identified by the Chemical Abstracts Service Number (CAS No.) 112930-95-7, is a versatile heterocyclic compound that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound belongs to the pyrimidine family, which is well-documented for its broad spectrum of biological activities and utility in drug development. The presence of both an iodine substituent at the 2-position and a trifluoromethyl group at the 5-position imparts unique reactivity and electronic properties, making it a valuable intermediate in synthetic chemistry.

The trifluoromethyl group is particularly noteworthy due to its ability to enhance metabolic stability, lipophilicity, and binding affinity in biological targets. This feature has been extensively leveraged in medicinal chemistry to optimize drug-like properties. In contrast, the iodo substituent serves as an excellent handle for further functionalization via cross-coupling reactions, such as Suzuki-Miyaura, Stille, or Sonogashira couplings. These reactions are pivotal in constructing complex molecular architectures, enabling the synthesis of novel therapeutic agents.

Recent advancements in the field of pyrimidine-based drug discovery have highlighted the importance of 2-Iodo-5-(trifluoromethyl)pyrimidine as a building block. For instance, studies have demonstrated its utility in the development of kinase inhibitors, which are critical in treating cancers and inflammatory diseases. The trifluoromethyl group's electron-withdrawing nature modulates the electronic distribution of the pyrimidine ring, facilitating interactions with biological targets such as protein kinases. Additionally, the iodine atom allows for precise modifications, enabling the introduction of diverse pharmacophores.

In an intriguing study published in 2023, researchers utilized 2-Iodo-5-(trifluoromethyl)pyrimidine to synthesize a series of substituted pyrimidines targeting Janus kinases (JAKs). The compound served as a precursor for generating analogs with enhanced binding affinity to JAK enzymes, which play a crucial role in signal transduction pathways associated with autoimmune disorders. The study reported that compounds derived from this scaffold exhibited promising inhibitory activity with improved selectivity over off-target kinases.

The agrochemical sector has also benefited from the versatility of 2-Iodo-5-(trifluoromethyl)pyrimidine. Its incorporation into novel herbicides and fungicides has led to formulations with improved efficacy and environmental safety. The trifluoromethyl group contributes to the stability of these compounds under various conditions, while the iodine moiety enables further derivatization to achieve desired biological activity against plant pathogens or weeds. This dual functionality makes it an attractive candidate for designing next-generation crop protection agents.

Synthetic methodologies involving 2-Iodo-5-(trifluoromethyl)pyrimidine have seen significant innovation in recent years. Transition-metal-catalyzed reactions remain a cornerstone for transforming this intermediate into more complex molecules. For example, palladium-catalyzed cross-coupling reactions have been employed to introduce aryl or vinyl groups at various positions of the pyrimidine ring, expanding its synthetic utility. These strategies are particularly valuable in constructing heterocyclic libraries for high-throughput screening campaigns.

The pharmaceutical industry continues to explore new applications for 2-Iodo-5-(trifluoromethyl)pyrimidine in targeted therapies. Researchers have investigated its potential in developing antiviral agents, where modifications at the 2- and 5-positions can fine-tune interactions with viral proteases or polymerases. Additionally, its role in creating small-molecule inhibitors for bacterial resistance mechanisms has been examined, offering hope for addressing rising antibiotic resistance challenges.

From a computational chemistry perspective, studies have focused on understanding the electronic structure and reactivity of 2-Iodo-5-(trifluoromethyl)pyrimidine using advanced modeling techniques. Density functional theory (DFT) calculations have provided insights into how the trifluoromethyl and iodine substituents influence charge distribution and reaction pathways. These findings are instrumental in guiding synthetic design and optimizing reaction conditions for maximum yield and purity.

The future prospects of 2-Iodo-5-(trifluoromethyl)pyrimidine are promising, with ongoing research aimed at uncovering new applications and improving existing synthetic routes. Collaborative efforts between academia and industry are expected to drive innovation in this area, leading to breakthroughs in drug discovery and agrochemical development. As our understanding of molecular interactions deepens, compounds like this will continue to play a pivotal role in advancing scientific and technological progress.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)